Meet Our Team

The People Behind PSI

Psychedelic Science Institute was founded by a multidisciplinary team of leaders in neuroscience, mental health, psychedelic medicine, and healthcare strategy, bringing together the expertise of the TRIP Center at Pacific Neuroscience Institute and the California Center for Psychedelic Therapy. Our physicians, psychologists, psychotherapists, psychiatric nurses, and research professionals are united by a shared commitment to advancing the science and responsible implementation of psychedelic medicines.

colorful concept art of a woman

Since 2018, our team has delivered more than 12,000 ketamine-assisted psychotherapy (KAP) sessions and participated in multiple clinical trials evaluating investigational psychedelic medicines. Together, we are helping build the evidence, clinical expertise, and care delivery model needed to responsibly integrate these therapies into mainstream healthcare.

Founders

Daniel Kelly, MD

Chief Executive Officer

Keith Heinzerling, MD, MPH

Chief Medical & Science Officer

Brooke Balliett, LMFT

Chief Operating Officer

Micah Linton, PsyD

Chief Clinical & Innovation Officer

Gregory Kearns, MHA

Chief Strategy & Business Development Officer

Advisors

Kyle Moore, MHA

Strategic Finance Advisor

Divya Malhotra

Technology & Data Advisor

Mike Avila

Philanthropic Advisor

Our Team

Leah Bedrosian, MPH

Clinical Research Manager

Kyrsten Cardenas

Business Operations Manager

Jose Fregoso, MSN, PMHNP

Psychiatric Mental Health Nurse Practitioner

Taira Chaudry, PMHNP-BC

Psychiatric Mental Health Nurse Practitioner

Juliana N. Hudson, LCSW

Psychotherapist

Oliver Goldsmith

Senior Clinical Research Coordinator

Ashley Ramos

Senior Clinical Research Coordinator

Jamie Carrafa

Front Desk Coordinator

Dayra Alamo

Front Desk Coordinator

Ramon Elizondo, RN

Registered Nurse